Concepts (227)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Bariatric Surgery | 13 | 2024 | 203 | 2.130 |
Why?
|
| Obesity, Morbid | 12 | 2024 | 242 | 1.820 |
Why?
|
| Pandemics | 4 | 2020 | 807 | 1.000 |
Why?
|
| Surgery Department, Hospital | 3 | 2020 | 43 | 0.920 |
Why?
|
| Laparoscopy | 9 | 2020 | 767 | 0.880 |
Why?
|
| Esophagectomy | 3 | 2017 | 91 | 0.790 |
Why?
|
| Infection Control | 3 | 2020 | 128 | 0.780 |
Why?
|
| Perioperative Care | 4 | 2019 | 173 | 0.770 |
Why?
|
| Patient Selection | 4 | 2020 | 689 | 0.720 |
Why?
|
| Pneumonia, Viral | 3 | 2020 | 329 | 0.690 |
Why?
|
| Coronavirus Infections | 3 | 2020 | 315 | 0.680 |
Why?
|
| Postoperative Complications | 9 | 2023 | 2454 | 0.630 |
Why?
|
| Disease Transmission, Infectious | 1 | 2020 | 58 | 0.630 |
Why?
|
| Stomach Neoplasms | 7 | 2020 | 296 | 0.620 |
Why?
|
| Health Resources | 1 | 2020 | 80 | 0.620 |
Why?
|
| Weight Loss | 7 | 2023 | 238 | 0.620 |
Why?
|
| Gastric Bypass | 6 | 2017 | 112 | 0.590 |
Why?
|
| Decision Making | 2 | 2020 | 680 | 0.550 |
Why?
|
| Gastrectomy | 4 | 2013 | 70 | 0.540 |
Why?
|
| Smoke | 1 | 2017 | 27 | 0.530 |
Why?
|
| Health Communication | 1 | 2017 | 14 | 0.520 |
Why?
|
| Carbon Monoxide | 1 | 2017 | 93 | 0.520 |
Why?
|
| Endoscopy, Gastrointestinal | 2 | 2008 | 160 | 0.500 |
Why?
|
| Clinical Protocols | 1 | 2017 | 157 | 0.500 |
Why?
|
| Triage | 3 | 2020 | 125 | 0.460 |
Why?
|
| Esophageal Neoplasms | 3 | 2020 | 338 | 0.430 |
Why?
|
| Obesity | 4 | 2017 | 1006 | 0.430 |
Why?
|
| Length of Stay | 2 | 2017 | 790 | 0.430 |
Why?
|
| Thoracic Surgery, Video-Assisted | 1 | 2014 | 33 | 0.420 |
Why?
|
| Metabolic Diseases | 2 | 2015 | 55 | 0.420 |
Why?
|
| Malabsorption Syndromes | 2 | 2009 | 22 | 0.400 |
Why?
|
| Quality Improvement | 3 | 2023 | 474 | 0.360 |
Why?
|
| Pneumonectomy | 1 | 2014 | 214 | 0.360 |
Why?
|
| Minimally Invasive Surgical Procedures | 1 | 2014 | 275 | 0.360 |
Why?
|
| Robotics | 1 | 2014 | 270 | 0.340 |
Why?
|
| Humans | 49 | 2024 | 92367 | 0.340 |
Why?
|
| Surgical Stapling | 1 | 2010 | 17 | 0.330 |
Why?
|
| Gastroplasty | 1 | 2010 | 26 | 0.320 |
Why?
|
| Fundoplication | 1 | 2010 | 71 | 0.320 |
Why?
|
| Hospitals | 2 | 2023 | 313 | 0.300 |
Why?
|
| Gastroesophageal Reflux | 1 | 2010 | 115 | 0.300 |
Why?
|
| Lung Diseases | 1 | 2011 | 282 | 0.300 |
Why?
|
| Betacoronavirus | 3 | 2020 | 270 | 0.290 |
Why?
|
| Hospital Mortality | 1 | 2011 | 445 | 0.290 |
Why?
|
| Stomach | 1 | 2008 | 111 | 0.280 |
Why?
|
| Foreign Bodies | 1 | 2008 | 64 | 0.280 |
Why?
|
| Biliopancreatic Diversion | 1 | 2006 | 3 | 0.260 |
Why?
|
| Anticoagulants | 3 | 2020 | 448 | 0.260 |
Why?
|
| Peutz-Jeghers Syndrome | 1 | 2006 | 9 | 0.260 |
Why?
|
| Retrospective Studies | 14 | 2024 | 9695 | 0.260 |
Why?
|
| Intestines | 1 | 2009 | 426 | 0.250 |
Why?
|
| Digestive System Surgical Procedures | 3 | 2018 | 134 | 0.240 |
Why?
|
| Venous Thromboembolism | 2 | 2020 | 165 | 0.240 |
Why?
|
| Surgical Wound Infection | 2 | 2019 | 225 | 0.240 |
Why?
|
| Internet | 2 | 2020 | 331 | 0.240 |
Why?
|
| Middle Aged | 19 | 2024 | 27057 | 0.230 |
Why?
|
| Adenocarcinoma | 4 | 2020 | 1190 | 0.210 |
Why?
|
| Risk Assessment | 4 | 2020 | 2368 | 0.210 |
Why?
|
| Vulnerable Populations | 1 | 2024 | 84 | 0.210 |
Why?
|
| Male | 22 | 2024 | 43935 | 0.200 |
Why?
|
| Treatment Outcome | 10 | 2023 | 8729 | 0.190 |
Why?
|
| Colectomy | 2 | 2020 | 179 | 0.180 |
Why?
|
| Double-Balloon Enteroscopy | 1 | 2021 | 11 | 0.180 |
Why?
|
| Guideline Adherence | 2 | 2020 | 239 | 0.180 |
Why?
|
| Adult | 17 | 2024 | 27558 | 0.170 |
Why?
|
| Intestinal Diseases | 1 | 2021 | 80 | 0.170 |
Why?
|
| Health Services Accessibility | 1 | 2024 | 452 | 0.160 |
Why?
|
| Chemoprevention | 1 | 2020 | 93 | 0.160 |
Why?
|
| Efficiency, Organizational | 1 | 2020 | 58 | 0.160 |
Why?
|
| Female | 20 | 2024 | 47911 | 0.160 |
Why?
|
| Patient Care Bundles | 1 | 2019 | 21 | 0.160 |
Why?
|
| Aged | 10 | 2020 | 19949 | 0.150 |
Why?
|
| Operating Rooms | 1 | 2020 | 134 | 0.150 |
Why?
|
| Glucuronosyltransferase | 1 | 2020 | 186 | 0.150 |
Why?
|
| Venous Thrombosis | 2 | 2014 | 255 | 0.150 |
Why?
|
| Elective Surgical Procedures | 1 | 2020 | 155 | 0.150 |
Why?
|
| Risk | 1 | 2020 | 661 | 0.150 |
Why?
|
| Body Mass Index | 3 | 2017 | 798 | 0.140 |
Why?
|
| Fires | 1 | 2017 | 21 | 0.130 |
Why?
|
| Thinness | 1 | 2017 | 45 | 0.130 |
Why?
|
| Hemorrhage | 1 | 2018 | 290 | 0.130 |
Why?
|
| Enoxaparin | 1 | 2016 | 24 | 0.130 |
Why?
|
| Hyperparathyroidism, Secondary | 1 | 2016 | 69 | 0.120 |
Why?
|
| Logistic Models | 3 | 2019 | 1239 | 0.120 |
Why?
|
| Mentors | 1 | 2017 | 95 | 0.120 |
Why?
|
| Thrombosis | 1 | 2018 | 313 | 0.120 |
Why?
|
| Heparin | 1 | 2016 | 185 | 0.120 |
Why?
|
| Cystectomy | 1 | 2016 | 114 | 0.120 |
Why?
|
| Chicago | 1 | 2020 | 1464 | 0.120 |
Why?
|
| Severity of Illness Index | 2 | 2011 | 1920 | 0.110 |
Why?
|
| Diaphragm | 1 | 2014 | 52 | 0.110 |
Why?
|
| Respiration Disorders | 1 | 2014 | 40 | 0.110 |
Why?
|
| Circadian Rhythm | 1 | 2016 | 297 | 0.110 |
Why?
|
| Insulin Resistance | 1 | 2016 | 373 | 0.110 |
Why?
|
| Hospitals, Low-Volume | 1 | 2013 | 20 | 0.100 |
Why?
|
| Amyotrophic Lateral Sclerosis | 1 | 2014 | 146 | 0.100 |
Why?
|
| Smoking | 1 | 2017 | 639 | 0.100 |
Why?
|
| Surgeons | 1 | 2017 | 263 | 0.100 |
Why?
|
| Specialties, Surgical | 1 | 2013 | 70 | 0.100 |
Why?
|
| Prognosis | 4 | 2016 | 3871 | 0.100 |
Why?
|
| Illinois | 3 | 2023 | 502 | 0.100 |
Why?
|
| Analysis of Variance | 2 | 2011 | 899 | 0.090 |
Why?
|
| Carcinoma, Lobular | 1 | 2012 | 81 | 0.090 |
Why?
|
| Practice Guidelines as Topic | 3 | 2019 | 1076 | 0.090 |
Why?
|
| Cadherins | 1 | 2012 | 167 | 0.090 |
Why?
|
| Pilot Projects | 1 | 2014 | 901 | 0.090 |
Why?
|
| Patient Care Team | 1 | 2014 | 297 | 0.090 |
Why?
|
| Heart-Assist Devices | 1 | 2018 | 864 | 0.080 |
Why?
|
| Surgical Staplers | 1 | 2010 | 10 | 0.080 |
Why?
|
| Diverticulum, Esophageal | 1 | 2010 | 6 | 0.080 |
Why?
|
| Internationality | 3 | 2015 | 71 | 0.080 |
Why?
|
| Adolescent | 4 | 2017 | 9493 | 0.080 |
Why?
|
| Prospective Studies | 2 | 2019 | 4473 | 0.080 |
Why?
|
| Chondrodysplasia Punctata | 1 | 2009 | 7 | 0.080 |
Why?
|
| Duodenum | 2 | 2007 | 105 | 0.080 |
Why?
|
| Vitamin K Deficiency | 1 | 2009 | 5 | 0.080 |
Why?
|
| Models, Biological | 1 | 2016 | 1784 | 0.080 |
Why?
|
| Neoplasm Invasiveness | 1 | 2011 | 569 | 0.080 |
Why?
|
| Aged, 80 and over | 3 | 2020 | 6918 | 0.080 |
Why?
|
| Cohort Studies | 2 | 2016 | 2980 | 0.070 |
Why?
|
| Multivariate Analysis | 1 | 2011 | 995 | 0.070 |
Why?
|
| Disease-Free Survival | 1 | 2011 | 1178 | 0.070 |
Why?
|
| Genetic Testing | 1 | 2012 | 550 | 0.070 |
Why?
|
| Heart Failure | 1 | 2018 | 1341 | 0.070 |
Why?
|
| Sex Factors | 1 | 2011 | 1094 | 0.070 |
Why?
|
| Marfan Syndrome | 1 | 2007 | 28 | 0.070 |
Why?
|
| Survival Analysis | 1 | 2011 | 1512 | 0.070 |
Why?
|
| Endoscopy, Digestive System | 1 | 2007 | 70 | 0.070 |
Why?
|
| Vitamin D Deficiency | 1 | 2008 | 105 | 0.070 |
Why?
|
| Hernia, Hiatal | 1 | 2007 | 36 | 0.070 |
Why?
|
| Radiography | 1 | 2008 | 794 | 0.060 |
Why?
|
| Age Factors | 1 | 2011 | 1903 | 0.060 |
Why?
|
| Predictive Value of Tests | 1 | 2011 | 1761 | 0.060 |
Why?
|
| Pregnancy Complications | 1 | 2009 | 346 | 0.060 |
Why?
|
| Vena Cava Filters | 1 | 2007 | 88 | 0.060 |
Why?
|
| Comorbidity | 1 | 2010 | 986 | 0.060 |
Why?
|
| Prosthesis Implantation | 1 | 2007 | 130 | 0.060 |
Why?
|
| Neoplasm Staging | 1 | 2011 | 2032 | 0.060 |
Why?
|
| Device Removal | 1 | 2007 | 165 | 0.060 |
Why?
|
| Positron-Emission Tomography | 2 | 2020 | 342 | 0.060 |
Why?
|
| Pulmonary Embolism | 1 | 2007 | 232 | 0.050 |
Why?
|
| Incidence | 2 | 2020 | 1661 | 0.050 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2012 | 2397 | 0.050 |
Why?
|
| Sleep Apnea, Obstructive | 1 | 2006 | 215 | 0.050 |
Why?
|
| Follow-Up Studies | 2 | 2007 | 3775 | 0.050 |
Why?
|
| Young Adult | 2 | 2017 | 6627 | 0.050 |
Why?
|
| Benchmarking | 1 | 2023 | 80 | 0.050 |
Why?
|
| Diagnosis, Differential | 1 | 2006 | 1593 | 0.050 |
Why?
|
| Mutation | 1 | 2012 | 4215 | 0.040 |
Why?
|
| Computer Simulation | 1 | 2005 | 1112 | 0.040 |
Why?
|
| Infectious Disease Transmission, Patient-to-Professional | 1 | 2020 | 32 | 0.040 |
Why?
|
| Personal Protective Equipment | 1 | 2020 | 36 | 0.040 |
Why?
|
| Leucovorin | 1 | 2020 | 222 | 0.040 |
Why?
|
| Intestine, Small | 1 | 2021 | 300 | 0.040 |
Why?
|
| Healthcare Disparities | 1 | 2024 | 443 | 0.040 |
Why?
|
| Child | 2 | 2020 | 7310 | 0.040 |
Why?
|
| Inpatients | 2 | 2016 | 333 | 0.040 |
Why?
|
| Postoperative Care | 2 | 2013 | 238 | 0.040 |
Why?
|
| Gastrointestinal Hemorrhage | 1 | 2021 | 244 | 0.040 |
Why?
|
| Cross Infection | 1 | 2020 | 153 | 0.040 |
Why?
|
| Breast Neoplasms | 1 | 2012 | 3054 | 0.040 |
Why?
|
| Fluorouracil | 1 | 2020 | 549 | 0.040 |
Why?
|
| Cell Cycle | 1 | 2000 | 515 | 0.030 |
Why?
|
| Cell Cycle Proteins | 1 | 2000 | 406 | 0.030 |
Why?
|
| Risk Factors | 3 | 2017 | 5706 | 0.030 |
Why?
|
| CLOCK Proteins | 1 | 2016 | 15 | 0.030 |
Why?
|
| Personal Satisfaction | 1 | 2017 | 67 | 0.030 |
Why?
|
| Carrier Proteins | 1 | 2000 | 679 | 0.030 |
Why?
|
| Interprofessional Relations | 1 | 2017 | 120 | 0.030 |
Why?
|
| Overweight | 1 | 2017 | 120 | 0.030 |
Why?
|
| Sweden | 1 | 2015 | 41 | 0.030 |
Why?
|
| Cooperative Behavior | 1 | 2017 | 181 | 0.030 |
Why?
|
| Body Weight | 1 | 2017 | 454 | 0.030 |
Why?
|
| Program Evaluation | 1 | 2017 | 316 | 0.030 |
Why?
|
| Blood Transfusion | 1 | 2016 | 169 | 0.030 |
Why?
|
| Genotype | 1 | 2020 | 1865 | 0.030 |
Why?
|
| Preoperative Care | 2 | 2008 | 405 | 0.030 |
Why?
|
| Cross-Sectional Studies | 1 | 2020 | 1772 | 0.030 |
Why?
|
| Robotic Surgical Procedures | 1 | 2020 | 342 | 0.030 |
Why?
|
| DNA-Binding Proteins | 1 | 2000 | 1248 | 0.030 |
Why?
|
| Gastrointestinal Stromal Tumors | 1 | 2012 | 23 | 0.020 |
Why?
|
| Databases, Factual | 1 | 2017 | 955 | 0.020 |
Why?
|
| Gastric Mucosa | 1 | 2012 | 68 | 0.020 |
Why?
|
| Treatment Failure | 1 | 2012 | 289 | 0.020 |
Why?
|
| Lymphatic Metastasis | 1 | 2014 | 498 | 0.020 |
Why?
|
| Transcription Factors | 1 | 2000 | 1691 | 0.020 |
Why?
|
| Societies, Medical | 1 | 2015 | 602 | 0.020 |
Why?
|
| Lymph Node Excision | 1 | 2013 | 225 | 0.020 |
Why?
|
| Gene Expression Regulation | 1 | 2000 | 2011 | 0.020 |
Why?
|
| Tomography, X-Ray Computed | 2 | 2014 | 2685 | 0.020 |
Why?
|
| Antigens, CD | 1 | 2012 | 473 | 0.020 |
Why?
|
| Family | 1 | 2012 | 324 | 0.020 |
Why?
|
| Combined Modality Therapy | 1 | 2014 | 1733 | 0.020 |
Why?
|
| Disease Management | 1 | 2012 | 341 | 0.020 |
Why?
|
| Antineoplastic Combined Chemotherapy Protocols | 1 | 2020 | 2555 | 0.020 |
Why?
|
| Pregnancy, High-Risk | 1 | 2009 | 16 | 0.020 |
Why?
|
| Surveys and Questionnaires | 1 | 2017 | 2734 | 0.020 |
Why?
|
| Antineoplastic Agents | 1 | 2020 | 2366 | 0.020 |
Why?
|
| Indiana | 1 | 2008 | 13 | 0.020 |
Why?
|
| Fatal Outcome | 1 | 2009 | 299 | 0.020 |
Why?
|
| Abnormalities, Multiple | 1 | 2009 | 236 | 0.020 |
Why?
|
| Gastroscopy | 1 | 2007 | 24 | 0.020 |
Why?
|
| United States | 1 | 2020 | 7370 | 0.020 |
Why?
|
| Aortic Rupture | 1 | 2007 | 57 | 0.020 |
Why?
|
| Esophagoscopy | 1 | 2007 | 90 | 0.020 |
Why?
|
| Radiography, Interventional | 1 | 2007 | 143 | 0.020 |
Why?
|
| Posture | 1 | 2006 | 123 | 0.020 |
Why?
|
| Prosthesis Design | 1 | 2007 | 304 | 0.020 |
Why?
|
| Intraoperative Care | 1 | 2006 | 84 | 0.010 |
Why?
|
| Ambulatory Surgical Procedures | 1 | 2006 | 81 | 0.010 |
Why?
|
| Feasibility Studies | 1 | 2007 | 800 | 0.010 |
Why?
|
| Terminology as Topic | 1 | 2006 | 224 | 0.010 |
Why?
|
| Prevalence | 1 | 2008 | 1297 | 0.010 |
Why?
|
| Evidence-Based Medicine | 1 | 2006 | 448 | 0.010 |
Why?
|
| Educational Measurement | 1 | 2005 | 235 | 0.010 |
Why?
|
| Infant, Newborn | 1 | 2009 | 2506 | 0.010 |
Why?
|
| Models, Theoretical | 1 | 2005 | 497 | 0.010 |
Why?
|
| Pregnancy | 1 | 2009 | 3113 | 0.010 |
Why?
|
| Oxygen | 1 | 2006 | 762 | 0.010 |
Why?
|
| Education, Medical, Graduate | 1 | 2005 | 414 | 0.010 |
Why?
|
| Retinoblastoma-Binding Protein 1 | 1 | 2000 | 10 | 0.010 |
Why?
|
| E2F Transcription Factors | 1 | 2000 | 19 | 0.010 |
Why?
|
| S Phase | 1 | 2000 | 64 | 0.010 |
Why?
|
| Clinical Competence | 1 | 2005 | 809 | 0.010 |
Why?
|
| Time Factors | 1 | 2007 | 5429 | 0.010 |
Why?
|
| Cells, Cultured | 1 | 2000 | 2904 | 0.010 |
Why?
|
| Animals | 1 | 2000 | 28062 | 0.000 |
Why?
|